SCIENTIFIC PROTEIN LABORATORIES
LIVE

Serial Number

97898962

Owner

Hepalink USA Inc.

Attorney

Gordon M. Wright

First Use Date

Jan 1, 1976

Filing Date

Apr 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SCIENTIFIC PROTEIN LABORATORIES Trademark

Serial Number: 97898962 • Registration: 7561177

SCIENTIFIC PROTEIN LABORATORIES is a trademark filed by Hepalink USA Inc. on April 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Hepalink USA Inc. (8 trademarks)

2005 Cabot Boulevard West, Suite 200
Langhorne, PA 190471885

Entity Type: 03

Trademark Details

Filing Date

April 20, 2023

Registration Date

November 5, 2024

First Use Anywhere

January 1, 1976

First Use in Commerce

January 1, 1976

Goods & Services

Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans and animals for the prevention and treatment of thrombotic events and to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for use in coating medical devices to prevent blood clotting and thrombotic events; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Nov 5, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Sep 26, 2024 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 9, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 4, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 5, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 5, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 5, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2023 NWOS
NEW APPLICATION ENTERED
Apr 24, 2023 NWAP